Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide in primary breast cancer
NCT02676986Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Aug 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of enzalutamide in breast cancer, sponsored by Queen Mary University of London. Started Aug 2015; status: completed.
02
Drugs
enzalutamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02676986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676986.